Ketamine and Psychedelics
Matthew discusses the FDA-approved spray form of ketamine for treatment-resistant depression, emphasizing its rapid but short-lived effects compared to classic psychedelics like psilocybin. He highlights historical research on higher doses of ketamine used as psychedelic therapy, which showed promising results for addiction treatment. The potential for improved outcomes through a psychedelic approach to ketamine therapy remains largely unexplored.In this clip
From this podcast
Huberman Lab
Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38
Related Questions